-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UmZXEyYJk/CxUZ2j3sCknvnY/yODY9yNi015Lqz0IeDrag2pXZNLGSVEnJCD2wTm 6heb7fraTOnQO6WXtVnLmg== 0001005477-97-001564.txt : 19970526 0001005477-97-001564.hdr.sgml : 19970526 ACCESSION NUMBER: 0001005477-97-001564 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19970414 ITEM INFORMATION: Other events FILED AS OF DATE: 19970523 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN PHARMACEUTICAL CO /DE CENTRAL INDEX KEY: 0000864494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841139559 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-24158 FILM NUMBER: 97613290 BUSINESS ADDRESS: STREET 1: 200 WEBRO RD CITY: PARSIPPANY STATE: NJ ZIP: 07054-2823 BUSINESS PHONE: 2017795300 FORMER COMPANY: FORMER CONFORMED NAME: BRASEL VENTURES INC DATE OF NAME CHANGE: 19930328 8-K 1 FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ------------------------ FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 April 14, 1997 ------------------------------ Date of Report AMERICAN PHARMACEUTICAL COMPANY ----------------------------------------- (Exact name of Registrant as Specified in Charter) DELAWARE 33-35153-D 84-1138558 - ------------------------------------------------------------------------------ (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) 200 WEBRO ROAD PARSIPPANY, NEW JERSEY 07054 - ------------------------------------------------------------------------------ (Address of Principal Executive Offices) (Zip Code) (201)-515-1000 - ------------------------------------------------------------------------------ (Registrant's telephone number, including area code) Item 5. Other Events On April 14, 1997, by unanimous written consent, the Directors of American Pharmaceutical Company extended to expiration date of the Company's Class B and Class C Warrants to October 31, 1997. SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed in its behalf by the undersigned thereunto duly authorized. AMERICAN PHARMACEUTICAL COMPANY DATED April 14, 1997 By: /s/Christian M. Van Pelt -------------------------------------------- Christian M. Van Pelt, Chairman of the Board & Secretary DATED April 14, 1997 By: /s/Alfred C. Bagwell -------------------------------------------- Alfred C. Bagwell, President & CEO -----END PRIVACY-ENHANCED MESSAGE-----